SS
PDSB icon

SBI Securities’s PDS Biotechnology PDSB Stock Holding History

SBI Securities’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100 Sell
113
-5
-4% -$5 ﹤0.01% 3511
2026
Q1 		$71 Buy
118
+9
+8% +$7 ﹤0.01% 3500
2025
Q4 		$84 Sell
109
-1
-0.9% -$1 ﹤0.01% 3460
2025
Q3 		$111 Sell
110
-97
-47% -$114 ﹤0.01% 3488
2025
Q2 		$275 Buy
207
+101
+95% +$137 ﹤0.01% 3207
2025
Q1 		$126 Hold
106
– – ﹤0.01% 3375
2024
Q4 		$173 Buy
+106
New +$281 ﹤0.01% 3291

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

SBI Securities's PDSB Position: Q2 2026 in Review

SBI Securities reduced its PDS Biotechnology (PDSB) stake by 4.2% in Q2 2026, selling an estimated $5 and leaving 113 shares worth $100. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

SBI Securities first reported a position in PDSB in Q4 2024 and has held it in 7 quarters since. The position peaked at $275 in Q2 2025. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • SBI Securities held 113 shares of PDS Biotechnology worth $100 as of Q2 2026.
  • SBI Securities sold 5 PDS Biotechnology shares in Q2 2026, an estimated $5.
  • PDS Biotechnology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3511 holding.
  • SBI Securities first reported a position in PDS Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's PDS Biotechnology position peaked at $275 in Q2 2025.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.